15 November 2022: ERRATUM 
Errate: Hypoprothrombinemia During Cefmetazole Treatment: A Case Report
Yuichiro Haba1*, Hikaru Akizuki2, Naoyuki Hashiguchi2, Toshio Naito1DOI: 10.12659/AJCR.938954
Am J Case Rep 2022; 23:e938954
Abstract
ABSTRACT: The authors contacted the journal with the following corrections to the published article: 1. Table 1. PT-INR at 6th hospital day. 2.46 is incorrect; Correct: 2.47. 2. Table 2. Line 5, at Purpose of use of CMZ. NA is incorrect; Correct: Infection secondary to Pneumothorax. 3. Table 2. Line 11, at PT-INR, 2.46 is incorrect; Correct: 2.47. 4. References No. 22 and No. 23 are reversed. The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated. Reference: Yuichiro Haba, Hikaru Akizuki, Naoyuki Hashiguchi, Toshio Naito. Hypoprothrombinemia During Cefmetazole Treatment: A Case Report. Am J Case Rep. 2022; 23: e936712. DOI: 10.12659/AJCR.936712
Keywords: Humans, Cefmetazole, cephalosporins, Hypoprothrombinemias, Cephamycins
In Press
Case report 
Am J Case Rep In Press; DOI: 10.12659/AJCR.946041
Case report 
Am J Case Rep In Press; DOI: 10.12659/AJCR.947953
Case report 
Am J Case Rep In Press; DOI: 10.12659/AJCR.946932
Case report 
Am J Case Rep In Press; DOI: 10.12659/AJCR.947854
Most Viewed Current Articles
21 Jun 2024 : Case report
96,778
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report 
52,393
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report 
31,818
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
18 Feb 2024 : Case report
23,483
DOI :10.12659/AJCR.943030
Am J Case Rep 2024; 25:e943030